Education
About Us
Working with TipRanks
Follow Us
Sinovac Biotech (SVA)
NASDAQ:SVA
Participants Will Receive One Dose Of Vaccine (0.5 Ml) Of Sinovac Qiv, Vaxigrip Qiv
Influenza
Phase III
Not Yet Recruiting
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women
Sep 17, 2025
―
Ev71 Vaccine
Ev71 Vaccine
Phase IV
Completed
Clinical Trial for Batch Consistency of EV71 Vaccine
Jun 10, 2025
―
Rabies Vaccine, Verorab®
Rabies (Healthy Volunteers)
Phase III
Not Yet Recruiting
Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen
May 27, 2025
―
Rabies Vaccine (Serum-Free Vero Cell), Freeze-Dried, Verorab®
Rabies
Phase III
Not Yet Recruiting
Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen
May 27, 2025
―
Rabies Vaccine (Serum-Free Vero Cell), Freeze-Dried, Verorab®
Rabies
Phase II
Not Yet Recruiting
Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)
May 23, 2025
―
Low-Dose Of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell), Medium-Dose Tetravalent Inactivated Enterovirus Vaccine (Vero Cell), High-Dose Tetravalent Inactivated Enterovirus Vaccine (Vero Cell) ), Ev71 Inactivated Enterovirus Vaccine (Vero Cell) )(For Ages 6-71 Months）
Hand, Foot, And Mouth Disease (Hfmd), Herpangina
Phase I/II
Not Yet Recruiting
Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).
Dec 22, 2024
―
Bivalent Enterovirus Vaccine (Vero Cell), Inactivated, Enterovirus Type 71 Vaccine (Vero Cell), Inactivated
Hand, Foot, And Mouth Disease（Hfmd)
Phase III
Recruiting
Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)
Dec 04, 2024
―
Sipv
Poliomyelitis
Phase IV
Completed
Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers
Jan 29, 2024
―
Quadrivalent Influenza Vaccine(0.25Ml), Quadrivalent Influenza Vaccine(0.5Ml), Trivalent Influenza Vaccine(Bv), Trivalent Influenza Vaccine(By)
Seasonal Influenza
Phase III
Completed
A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
Sep 15, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sinovac Biotech (SVA) have in its pipeline
SVA is currently developing the following drugs: Participants Will Receive One Dose Of Vaccine (0.5 Ml) Of Sinovac Qiv, Vaxigrip Qiv, Ev71 Vaccine, Rabies Vaccine, Verorab®. These drug candidates are in various stages of clinical development as the company works toward FDA approval.